View Press Releases
-
CREBBP focused library from OTAVA
- Nov 7, 2014 - CREB-binding protein (CREBBP, CBP) is a transcriptional coactivator of a broad range of transcription factors
Nov 6, 2014
-
MolecularHealth to Speak at the 10th Annual Personalized Medicine Conference
THE WOODLANDS, TX, UNITED STATES - Nov 6, 2014 - MolecularHealth announced today that Medical Director Gabriel Bien-Willner, M.D., Ph.D., will speak at this years Personalized Medicine Conference
Nov 6, 2014
-
Takara Bio Selects Genedata Software to Automate and Standardize NGS Data Analysis
TOKYO, JAPAN - Nov 5, 2014 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Takara Bio Inc
Nov 7, 2014
-
Know More about Single-Cell Sequencing to Achieve More Biology Findings
SHIRLEY, NY - Nov 5, 2014 - As cell is the basic unit of biology, more and more scientists are trying to separate, study and compare cells
Nov 5, 2014
-
Cloud Pharmaceuticals Announces World-Class Board of Directors
RESEARCH TRIANGLE PARK, UNITED STATES - Nov 5, 2014 - Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today that it ratified its board of directors at its annual meeting on September 16, 2014
Nov 4, 2014
-
PRESS RELEASE: NEW STARTUP ‘BIO DATA BRIDGES’ OFFERS LAB DATA MANAGEMENT HEALTH CHECK™
SEATTLE, WA - Nov 4, 2014 - The challenge of future-proofing scientific data systems just got a lot easier for life science companies
Nov 4, 2014
-
SRA Joins the Global Alliance for Genomics and Health
NEW YORK, NY - Nov 4, 2014 - SRA International, Inc., a leading provider of IT solutions and professional services to government organizations, announced that it has joined the Global Alliance for Genomics and Health (Global Alliance) as an Organizational Member
Nov 7, 2014
-
Medidata and PPD Partner to Offer New Approach to Risk-Based Monitoring
NEW YORK, NY - Nov 4, 2014 - Medidata (NASDAQ: MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences, and Pharmaceutical Product Development, LLC (PPD), a global contract research organization (CRO), today announced they are expanding their partnership to provide the life science industry with a more comprehensive approach to risk-based monitoring (RBM)—aimed at conducting drug development more intelligently, more quickly and more cost-effectively
Nov 7, 2014
-
RainDance Technologies Appoints Martin M. Coyne II and Glenn P. Muir to Board of Directors
BILLERICA, MA - Nov 3, 2014 - RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of Martin M
Nov 3, 2014
-
A Brief Introduction of Creative Animodel’s Bioanalysis
SHIRLEY, NY - Nov 3, 2014 - Bioanalytical services help scientists to get more scientific findings. The professional team of Creative Animodel provides creative bioanalysis services, assuring the quality and cost of its services and products
Nov 3, 2014
-
Certara Updates Its Industry-Leading PK/PD Phoenix Platform and Introduces Phoenix Quantum Packages for Enhanced Collaboration and Efficiency
PRINCETON, NJ - Nov 3, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced the launch of version 1
Nov 3, 2014
-
A Brief Introduction of Creative Animodel’s Bioanalysis(2)
SHIRLEY, NY - Nov 3, 2014 - Bioanalytical services help scientists to get more scientific findings. The professional team of Creative Animodel provides creative bioanalysis services, assuring the quality and cost of its services and products
Nov 3, 2014
-
Medidata Selected by ASLAN Pharmaceuticals as Enterprise-Wide Technology Platform for Enhancing Clinical Development
NEW YORK, NY - Oct 30, 2014 - Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals, an oncology-focused biotechnology company
Nov 7, 2014
-
KCR Eliminates the Burden of Paper with Cloud-Based Content Management Solution
WARSAW, POLAND - Oct 28, 2014 - KCR, a European Contract Research Organization (CRO) operating across 19 European countries and in the US, has turned to the cloud in a move to improve cross-functional collaboration and trial operations
Oct 28, 2014
-
Personalized medicine: Genomics helps BC pharmacists target the right drugs for the right patient
VANCOUVER, BC, CANADA - Oct 28, 2014 - An exciting new research project that aims to make personalized medicine a reality for patients is launching in a number of community pharmacies across British Columbia
Oct 27, 2014
-
Dow Chemical Licenses Simulations Plus Software to Assist with Toxicology and Environmental Research
LANCASTER, CA - Oct 27, 2014 - Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for discovery and development, announced that The Dow Chemical Company (NYSE: DOW) has licensed both its best-in-class Oct 27, 2014
-
Whole Genome Resequencing: Using the Known to Find the Unknown
SHIRLEY, NY - Oct 26, 2014 - Whole genome resequencing is a laboratory process that determines the complete DNA sequence of an organism's genome which is already known
Oct 27, 2014
-
Certara Receives FDA Grant to Enhance Simcyp Simulator’s Mechanistic Dermal Absorption Model to Permit Drug Bioequivalence Assessment
ST. LOUIS, MO - Oct 23, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that it has received a Food and Drug Administration (FDA) Office of Generic Drugs grant (#1 U01 FD005225-01) to further develop and validate its Simcyp® Simulators mechanistic dermal absorption model, MechDermA
Oct 23, 2014
-
Certara Receives FDA Grant to Enhance Simcyp Simulator’s Mechanistic Dermal Absorption Model to Permit Drug Bioequivalence Assessment(2)
ST. LOUIS, MO - Oct 23, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that it has received a Food and Drug Administration (FDA) Office of Generic Drugs grant (#1 U01 FD005225-01) to further develop and validate its Simcyp® Simulators mechanistic dermal absorption model, MechDermA
Oct 23, 2014
-
Voltage-Gated Sodium Channel Blockers Library from OTAVA
TORONTO, CANADA - Oct 22, 2014 - Voltage-gated sodium channels are a class of large integral membrane proteins, composed of a highly processed α subunit and one or several smaller β subunits
Oct 22, 2014